Autoliv (ALV) Q4 2025 earnings review
Record Sales & Cash Flow Mask Margin Compression
Autoliv delivered record quarterly sales of $2.82B (+7.7% YoY) and record Operating Cash Flow of $544M, capitalizing on a strong rebound in China (+8.3% organic). However, the earnings quality shows cracks: Operating Income fell nearly 10% YoY as the company cycled past substantial one-off inflation compensations from 2024. While management touts the 'best quarter yet,' adjusted margins compressed 140bps to 12.0%. Looking ahead, the 2026 outlook implies a sharp deceleration to ~0% organic growth, relying entirely on cost cuts to eke out margin expansion in a flat production environment.
🐂 Bull Case
The China segment has executed a massive reversal, moving from -5.2% organic growth in 24Q4 to +8.3% in 25Q4. Success with domestic Chinese OEMs (COEMs) is the driver, with sales to this group surging ~40%.
Operating cash flow jumped 30% YoY to a record $544M. With CapEx disciplined at 3.9% of sales, Autoliv generated massive Free Cash Flow ($434M), fueling aggressive shareholder returns ($150M buybacks + $66M dividends in the quarter).
🐻 Bear Case
Guidance for 2026 projects ~0% organic sales growth. The company expects global Light Vehicle Production (LVP) to decline by 1%, removing the 'rising tide' that aided 2025.
Despite record sales volume, Gross Margin fell 70bps and Adjusted Operating Margin fell 140bps YoY. The loss of 'out-of-period customer compensations' exposes the underlying cost inflation (S,G&A +9.4% YoY).
⚖️ Verdict: ⚪
Neutral. The operational pivot in China and cash generation are excellent, but the profit decline on record sales is concerning. 2026 guidance suggests the company is entering a low-growth period where margin expansion relies solely on internal cost cutting rather than volume leverage.
Key Themes
China Momentum Accelerating
China has flipped from a laggard to the primary growth engine. Organic sales grew 8.3%, massively outperforming the regional LVP of +3.0%. The strategic pivot to domestic OEMs is paying off: sales to COEMs grew ~40%, while sales to global OEMs in China dropped 11%. COEMs now account for 30% of order intake, validating the 'In China, For China' strategy.
OpEx Inflation Outpacing Sales
While sales grew 7.7%, S,G&A expenses rose 9.4% ($144M) and R,D&E expenses jumped 28% ($94M). Management cited wage inflation and higher IT license costs. This negative operating leverage contributed to the 220bps compression in reported operating margin.
Cash Conversion & Shareholder Returns
Cash conversion (FCF / Net Income) hit 192% in Q4 (vs 118% prior year). This efficiency allowed Autoliv to accelerate buybacks to $150M in the quarter (up from $102M YoY) while paying $66M in dividends. Leverage ratio improved to 1.1x, well below the 1.5x ceiling, leaving ample room for continued returns in a flat 2026.
Tariff Neutrality
Autoliv has successfully insulated itself from trade war impacts. Management noted they recovered close to 100% of tariff costs in Q4 and >80% for the full year. While tariff compensations added ~1pp to sales growth, the dilutive effect on margin was minimal (15bps headwind).
Q1 2026 Profit Warning
CEO Mikael Bratt explicitly warned that 'Q1 2026 adjusted operating margin to be considerably weaker than Q1 2025.' This implies a difficult start to the year, likely due to the reset of customer pricing agreements and LVP seasonality, putting pressure on the back half of 2026 to hit targets.
Other KPIs
Decelerating. Down from 13.4% in 24Q4. While 12% is strong historically, the YoY decline highlights the difficulty of lapping 2024's retroactive inflation payments. The 1.4pp drop was driven by R&D costs and lower other income.
Accelerating. Up 30% YoY. A significant release of working capital ($205M positive impact) driven by lower receivables and improved inventory management towards quarter-end fueled this record result.
Decelerating. Down 3.8% YoY from $3.10. While share buybacks provided a $0.11 tailwind and lower taxes helped, they could not offset the $0.37 impact from lower operating income.
Guidance
Decelerating significantly from 3.4% in 2025. This assumes global LVP declines by 1%. The company expects to outperform LVP by ~1%, but currency will add another ~1%, leading to reported growth of ~1%.
Stable/Slight Acceleration. Midpoint (10.75%) implies a modest improvement over 2025's full-year result of 10.3%. Growth relies on cost-cutting and efficiency rather than volume leverage.
Stable. Roughly flat compared to 2025's record $1.16B. Indicates high conversion quality is expected to persist despite flat sales.
Key Questions
Margin Bridge for 2026
With organic growth guided to 0%, what are the specific buckets (headcount, material costs, efficiency) that will drive the margin expansion to 10.5-11.0%? How much of this is reliant on the 'commercial recoveries' that faded in Q4?
Q1 2026 Weakness
You flagged Q1 2026 margins would be 'considerably weaker' than Q1 2025 (9.9%). Does this imply a return to mid-single digit margins? What specific headwinds are concentrated in Q1?
China Mix Sustainability
Sales to Chinese domestic OEMs grew 40% while global OEMs in China fell 11%. Is this 40% growth rate a function of specific model launches that will normalize, or do you view this as a sustainable run-rate for 2026?
OpEx Discipline
S,G&A and R&D grew significantly faster than sales in Q4. With a flat sales outlook for 2026, what actions are being taken to realign the fixed cost base to a no-growth environment?